Constipation and bladder pressure Constipation is one of the most common semaglutide side effects , affecting roughly 12-20% of users depending on the dose
Claims of FDA approved on a compounded product: Compounded sermorelin is not FDA-approved
High Bioavailability Formula For Better Results
Yes, clinical trials confirm that GLP-1 medications are safe and effective for non-diabetic weight loss when prescribed and monitored appropriately
This week: tirzepatide vs semaglutide results from 20,000+ patients, new data on the start-and-stop journey, groundbreaking research on GLP-1s rewiring impulsive behaviour, and why your step count matters more than you think.Plus Father's Day waffle, World Cup chat, and the first ever fully integrated sponsor on the channel.This week's stories: Tirzepatide vs Semaglutide: Real-world data from 20,000+ patients The Start & Stop trend 58% restart within 2 years GLP-1s and impulsive behaviour: the brain rewiring study Physical activity drop & the muscle loss warning Check out all the update videos on YouTube: YouTube Weekly Videos *The episodes in this series are recorded as YouTube videos
In studies with rodents, GLP-1 receptor activation resulted in a reduction in nicotine self-administration
